Logo image of CRCT

CRICUT INC - CLASS A (CRCT) Stock Fundamental Analysis

NASDAQ:CRCT - Nasdaq - US22658D1000 - Common Stock - Currency: USD

5.53  -0.07 (-1.25%)

After market: 5.53 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CRCT. CRCT was compared to 67 industry peers in the Household Durables industry. While CRCT has a great health rating, its profitability is only average at the moment. CRCT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CRCT was profitable.
CRCT had a positive operating cash flow in the past year.
CRCT had positive earnings in each of the past 5 years.
Of the past 5 years CRCT 4 years had a positive operating cash flow.
CRCT Yearly Net Income VS EBIT VS OCF VS FCFCRCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

CRCT has a Return On Assets of 9.37%. This is in the better half of the industry: CRCT outperforms 73.85% of its industry peers.
CRCT's Return On Equity of 13.07% is in line compared to the rest of the industry. CRCT outperforms 56.92% of its industry peers.
With a decent Return On Invested Capital value of 12.72%, CRCT is doing good in the industry, outperforming 72.31% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRCT is in line with the industry average of 11.99%.
The last Return On Invested Capital (12.72%) for CRCT is above the 3 year average (12.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.37%
ROE 13.07%
ROIC 12.72%
ROA(3y)9.17%
ROA(5y)13.29%
ROE(3y)13.3%
ROE(5y)27.96%
ROIC(3y)12.7%
ROIC(5y)24.07%
CRCT Yearly ROA, ROE, ROICCRCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 20 40 60

1.3 Margins

CRCT has a better Profit Margin (8.47%) than 67.69% of its industry peers.
In the last couple of years the Profit Margin of CRCT has declined.
The Operating Margin of CRCT (12.08%) is better than 70.77% of its industry peers.
CRCT's Operating Margin has declined in the last couple of years.
CRCT's Gross Margin of 48.45% is amongst the best of the industry. CRCT outperforms 90.77% of its industry peers.
CRCT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.08%
PM (TTM) 8.47%
GM 48.45%
OM growth 3Y-20.65%
OM growth 5Y-2.11%
PM growth 3Y-24.24%
PM growth 5Y-13.54%
GM growth 3Y8.98%
GM growth 5Y6.53%
CRCT Yearly Profit, Operating, Gross MarginsCRCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRCT is creating some value.
CRCT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CRCT has been reduced compared to 5 years ago.
CRCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CRCT Yearly Shares OutstandingCRCT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
CRCT Yearly Total Debt VS Total AssetsCRCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

CRCT has an Altman-Z score of 6.07. This indicates that CRCT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.07, CRCT belongs to the top of the industry, outperforming 87.69% of the companies in the same industry.
CRCT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.07
ROIC/WACC1.39
WACC9.17%
CRCT Yearly LT Debt VS Equity VS FCFCRCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 3.16 indicates that CRCT has no problem at all paying its short term obligations.
CRCT's Current ratio of 3.16 is in line compared to the rest of the industry. CRCT outperforms 60.00% of its industry peers.
A Quick Ratio of 2.18 indicates that CRCT has no problem at all paying its short term obligations.
CRCT has a better Quick ratio (2.18) than 87.69% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 2.18
CRCT Yearly Current Assets VS Current LiabilitesCRCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

CRCT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
Measured over the past 5 years, CRCT shows a small growth in Earnings Per Share. The EPS has been growing by 2.10% on average per year.
Looking at the last year, CRCT shows a decrease in Revenue. The Revenue has decreased by -9.85% in the last year.
Measured over the past years, CRCT shows a quite strong growth in Revenue. The Revenue has been growing by 17.63% on average per year.
EPS 1Y (TTM)16.67%
EPS 3Y-29.61%
EPS 5Y2.1%
EPS Q2Q%-37.5%
Revenue 1Y (TTM)-9.85%
Revenue growth 3Y-7.25%
Revenue growth 5Y17.63%
Sales Q2Q%-4.01%

3.2 Future

CRCT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.64% yearly.
The Revenue is expected to decrease by -2.10% on average over the next years.
EPS Next Y18.79%
EPS Next 2Y11.97%
EPS Next 3Y12.64%
EPS Next 5YN/A
Revenue Next Year-8.03%
Revenue Next 2Y-4.26%
Revenue Next 3Y-2.1%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRCT Yearly Revenue VS EstimatesCRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
CRCT Yearly EPS VS EstimatesCRCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

CRCT is valuated rather expensively with a Price/Earnings ratio of 19.75.
CRCT's Price/Earnings ratio is in line with the industry average.
CRCT is valuated rather cheaply when we compare the Price/Earnings ratio to 28.42, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.38, which indicates a rather expensive current valuation of CRCT.
Based on the Price/Forward Earnings ratio, CRCT is valued a bit more expensive than the industry average as 61.54% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.39, CRCT is valued a bit cheaper.
Industry RankSector Rank
PE 19.75
Fwd PE 18.38
CRCT Price Earnings VS Forward Price EarningsCRCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRCT is valued a bit cheaper than 75.38% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRCT indicates a rather cheap valuation: CRCT is cheaper than 95.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.05
EV/EBITDA 7.14
CRCT Per share dataCRCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

CRCT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of CRCT may justify a higher PE ratio.
CRCT's earnings are expected to grow with 12.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.05
PEG (5Y)9.4
EPS Next 2Y11.97%
EPS Next 3Y12.64%

More info and screens

4

5. Dividend

5.1 Amount

CRCT has a Yearly Dividend Yield of 3.37%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.89, CRCT pays a better dividend. On top of this CRCT pays more dividend than 90.77% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, CRCT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.37%

5.2 History

CRCT has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRCT Yearly Dividends per shareCRCT Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

0.53% of the earnings are spent on dividend by CRCT. This is a low number and sustainable payout ratio.
DP0.53%
EPS Next 2Y11.97%
EPS Next 3Y12.64%
CRCT Yearly Income VS Free CF VS DividendCRCT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 100M -100M 200M
CRCT Dividend Payout.CRCT Dividend Payout, showing the Payout Ratio.CRCT Dividend Payout.PayoutRetained Earnings

More info and screens

CRICUT INC - CLASS A

NASDAQ:CRCT (1/28/2025, 8:00:00 PM)

After market: 5.53 0 (0%)

5.53

-0.07 (-1.25%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Inst Owners43.96%
Inst Owner Change0.19%
Ins Owners13.51%
Ins Owner Change13.32%
Market Cap1.19B
Analysts44.44
Price Target5.14 (-7.05%)
Short Float %9.15%
Short Ratio11.45
Dividend
Industry RankSector Rank
Dividend Yield 3.37%
Yearly Dividend1.34
Dividend Growth(5Y)N/A
DP0.53%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-07 2025-01-07 (0.1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)38.44%
Min EPS beat(2)-0.47%
Max EPS beat(2)77.36%
EPS beat(4)2
Avg EPS beat(4)31.98%
Min EPS beat(4)-8.66%
Max EPS beat(4)77.36%
EPS beat(8)4
Avg EPS beat(8)11.13%
EPS beat(12)4
Avg EPS beat(12)-3.59%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.86%
Min Revenue beat(2)-3.85%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-5.11%
Min Revenue beat(4)-9.2%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-4.33%
Revenue beat(12)2
Avg Revenue beat(12)-5.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.97%
EPS NY rev (1m)0%
EPS NY rev (3m)2.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.23%
Valuation
Industry RankSector Rank
PE 19.75
Fwd PE 18.38
P/S 1.61
P/FCF 5.05
P/OCF 4.67
P/B 2.49
P/tB 2.49
EV/EBITDA 7.14
EPS(TTM)0.28
EY5.06%
EPS(NY)0.3
Fwd EY5.44%
FCF(TTM)1.09
FCFY19.79%
OCF(TTM)1.18
OCFY21.42%
SpS3.42
BVpS2.22
TBVpS2.22
PEG (NY)1.05
PEG (5Y)9.4
Profitability
Industry RankSector Rank
ROA 9.37%
ROE 13.07%
ROCE 18.01%
ROIC 12.72%
ROICexc 25.52%
ROICexgc 25.52%
OM 12.08%
PM (TTM) 8.47%
GM 48.45%
FCFM 31.96%
ROA(3y)9.17%
ROA(5y)13.29%
ROE(3y)13.3%
ROE(5y)27.96%
ROIC(3y)12.7%
ROIC(5y)24.07%
ROICexc(3y)20.95%
ROICexc(5y)42.27%
ROICexgc(3y)20.99%
ROICexgc(5y)42.9%
ROCE(3y)17.98%
ROCE(5y)35.5%
ROICexcg growth 3Y-47.75%
ROICexcg growth 5Y-5.63%
ROICexc growth 3Y-47.39%
ROICexc growth 5Y-4.9%
OM growth 3Y-20.65%
OM growth 5Y-2.11%
PM growth 3Y-24.24%
PM growth 5Y-13.54%
GM growth 3Y8.98%
GM growth 5Y6.53%
F-Score7
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 63.67%
Cap/Sales 2.62%
Interest Coverage 250
Cash Conversion 213.52%
Profit Quality 377.42%
Current Ratio 3.16
Quick Ratio 2.18
Altman-Z 6.07
F-Score7
WACC9.17%
ROIC/WACC1.39
Cap/Depr(3y)129.56%
Cap/Depr(5y)139.31%
Cap/Sales(3y)3.22%
Cap/Sales(5y)2.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y-29.61%
EPS 5Y2.1%
EPS Q2Q%-37.5%
EPS Next Y18.79%
EPS Next 2Y11.97%
EPS Next 3Y12.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.85%
Revenue growth 3Y-7.25%
Revenue growth 5Y17.63%
Sales Q2Q%-4.01%
Revenue Next Year-8.03%
Revenue Next 2Y-4.26%
Revenue Next 3Y-2.1%
Revenue Next 5YN/A
EBIT growth 1Y31.41%
EBIT growth 3Y-26.4%
EBIT growth 5Y15.14%
EBIT Next Year73.11%
EBIT Next 3Y25.28%
EBIT Next 5YN/A
FCF growth 1Y3501.78%
FCF growth 3Y5.31%
FCF growth 5YN/A
OCF growth 1Y823.57%
OCF growth 3Y5.09%
OCF growth 5YN/A